Attached files
| file | filename |
|---|---|
| EX-99.2 - STATEMENTS OF BRIAN J. SMRDEL - UROLOGIX INC | urologix134521_ex99-2.htm |
| EX-99.1 - PRESS RELEASE ISSUED OCTOBER 29, 2013 - UROLOGIX INC | urologix134521_ex99-1.htm |
|
|
|
UNITED STATES |
|
SECURITIES AND EXCHANGE COMMISSION |
|
Washington, D.C. 20549 |
|
|
|
|
|
|
|
|
|
|
FORM 8-K |
|
|
|
|
|
CURRENT
REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (date of earliest event reported): October 29, 2013
|
|
|
|
|
|
|
|
|
|
Urologix, Inc. |
|
|
(Exact name of Registrant as Specified in its Charter) |
||
|
|
||
|
|
Minnesota |
|
|
(State Or Other Jurisdiction Of Incorporation) |
||
|
|
|
|
|
000-28414 |
|
41-1697237 |
|
(Commission File Number) |
|
(I.R.S. Employer Identification No.) |
|
|
|
|
|
|
14405 21st Avenue North |
|
|
|
|
Minneapolis, MN |
|
55447 |
|
|
(Address Of Principal Executive Offices) |
|
(Zip Code) |
|
|
|
|
|
|
|
(763) 475-1400 |
|
|
Registrant’s Telephone Number, Including Area Code |
||
|
|
|
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
|
|
o |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
o |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
o |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
o |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
|
|
|
Items under Sections 1 and 3 through 8 are not applicable and therefore omitted. |
|
|
|
ITEM 2.02 |
RESULTS OF OPERATIONS AND FINANCIAL CONDITION. |
Urologix, Inc. (the “Company”) hereby furnishes as Exhibit 99.1 a press release issued on October 29, 2013 disclosing material non-public information regarding the Company’s results of operations for the first fiscal quarter of fiscal year 2014 ended September 30, 2013 and hereby furnishes as Exhibit 99.2 statements of Brian J. Smrdel, the Company’s Chief Financial Officer, made on October 29, 2013 at a telephone conference relating to the quarter ended September 30, 2013 results.
|
|
|
|
ITEM 9.01 |
FINANCIAL STATEMENTS AND EXHIBITS. |
|
|
|
|
|
|
Exhibit No. |
|
Description |
|
|
|
|
|
99.1 |
|
Press Release issued on October 29, 2013. |
|
|
|
|
|
99.2 |
|
Statements of Brian J. Smrdel, Chief Financial Officer, of Urologix, Inc. at a telephone conference held on October 29, 2013. |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
|
|
|
|
|
|
|
UROLOGIX, INC. |
|
|
|
|
|
|
|
|
|
By: |
/s/ Brian J. Smrdel |
|
|
|
|
Brian J. Smrdel |
|
|
|
|
Chief Financial Officer |
|
|
|
|
|
|
|
Date: October 30, 2013 |
|
|
|